PHARMALA BIOTECH HLDG INC (MDXXF) SEC filings
MDXXF SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MDXXF overview →
3 measured MDXXF SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01 | Press release | +0.00% | -0.57% | |
| PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA | Press release | — | +0.00% | |
| PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA | Press release | +1.89% | +5.51% |
Keep exploring
More MDXXF: earnings → · analyst actions → · MDXXF overview →